Bentsur Ron's Form 4 filing
Nuvectis Pharma, Inc. (NVCT) · filed Jul 24, 2023
- Accession no.
- 0001104659-23-083472
- Filed
- Jul 24, 2023
- Trade date
- Jul 20-21, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.00K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bentsur RonCIK 0001251213 | Director, Officer (Chairman & CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2023 | Common Stock | PPurchaseAcquired | +110 | $15.06 | +$1,656.6 | 3,231,669 | Direct | |
| Jul 21, 2023 | Common Stock | PPurchaseAcquired | +225 | $14.85 | +$3,341.25 | 3,231,894 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.